Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CLADRIBINE Cause Progressive multifocal leukoencephalopathy? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Progressive multifocal leukoencephalopathy have been filed in association with CLADRIBINE (Cladribine). This represents 0.1% of all adverse event reports for CLADRIBINE.

6
Reports of Progressive multifocal leukoencephalopathy with CLADRIBINE
0.1%
of all CLADRIBINE reports
0
Deaths
4
Hospitalizations

How Dangerous Is Progressive multifocal leukoencephalopathy From CLADRIBINE?

Of the 6 reports, 4 (66.7%) required hospitalization.

Is Progressive multifocal leukoencephalopathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CLADRIBINE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does CLADRIBINE Cause?

Fatigue (696) Headache (579) Lymphocyte count decreased (448) Multiple sclerosis relapse (404) Nausea (354) Pneumonia (318) White blood cell count decreased (311) Urinary tract infection (242) Pyrexia (207) Multiple sclerosis (206)

What Other Drugs Cause Progressive multifocal leukoencephalopathy?

NATALIZUMAB (1,668) RITUXIMAB (1,647) CYCLOPHOSPHAMIDE (782) PREDNISONE (606) PREDNISOLONE (439) TACROLIMUS (438) METHOTREXATE (428) DOXORUBICIN (421) MYCOPHENOLATE MOFETIL (414) VINCRISTINE (376)

Which CLADRIBINE Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?

CLADRIBINE vs CLARAVIS CLADRIBINE vs CLARITHROMYCIN CLADRIBINE vs CLARITIN CLADRIBINE vs CLARITIN CHEWABLE CLADRIBINE vs CLARITIN-D-12

Related Pages

CLADRIBINE Full Profile All Progressive multifocal leukoencephalopathy Reports All Drugs Causing Progressive multifocal leukoencephalopathy CLADRIBINE Demographics